(Q39651410)

13 September 2017

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections (English)

1 reference

13 September 2017

Ellie J. C. Goldstein

series ordinal

1

object named as

Ellie J C Goldstein

1 reference

13 September 2017

5

Kerin L Tyrrell

1 reference

13 September 2017

2

Diane M Citron

1 reference

13 September 2017

3

C Vreni Merriam

1 reference

13 September 2017

4

Yumi A Warren

1 reference

13 September 2017

Helen Fernandez

6

1 reference

PMC publication ID

127089

13 September 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Antimicrobial Agents and Chemotherapy

13 September 2017

1 reference

13 September 2017

46

1 reference

13 September 2017

4

1 reference

13 September 2017

1136-1140

1 reference

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

United States National Hospital Survey of anaerobic culture and susceptibility methods, II.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127089

In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests

21 August 2018

1 reference

12 December 2020

Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295

1 reference

12 December 2020

Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis

1 reference

12 December 2020

Antimicrobial resistance in Bacteroides

1 reference

12 December 2020

10.1128/AAC.46.4.1136-1140.2002

Identifiers

DOI

1 reference

13 September 2017

1 reference

PMC publication ID

127089

13 September 2017

PubMed publication ID

11897608

1 reference

PMC publication ID

127089